123 related articles for article (PubMed ID: 11798136)
1. Mycobacterium-specific human CD8 T cell responses.
Klein MR; Fox A
Arch Immunol Ther Exp (Warsz); 2001; 49(5):379-89. PubMed ID: 11798136
[TBL] [Abstract][Full Text] [Related]
2. CD8+ T lymphocytes against mycobacterium tuberculosis.
Klein MR; McAdam KP
Arch Immunol Ther Exp (Warsz); 1999; 47(5):313-20. PubMed ID: 10604237
[TBL] [Abstract][Full Text] [Related]
3. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
4. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
5. Antigen load governs the differential priming of CD8 T cells in response to the bacille Calmette Guerin vaccine or Mycobacterium tuberculosis infection.
Ryan AA; Nambiar JK; Wozniak TM; Roediger B; Shklovskaya E; Britton WJ; Fazekas de St Groth B; Triccas JA
J Immunol; 2009 Jun; 182(11):7172-7. PubMed ID: 19454714
[TBL] [Abstract][Full Text] [Related]
6. A novel DNA vaccine containing multiple TB-specific epitopes cast in a natural structure elicits enhanced Th1 immunity compared with BCG.
Gao H; Li K; Yu S; Xiong S
Microbiol Immunol; 2009 Oct; 53(10):541-9. PubMed ID: 19780967
[TBL] [Abstract][Full Text] [Related]
7. High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection.
Hervas-Stubbs S; Majlessi L; Simsova M; Morova J; Rojas MJ; Nouzé C; Brodin P; Sebo P; Leclerc C
Infect Immun; 2006 Jun; 74(6):3396-407. PubMed ID: 16714570
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and protective efficacy of tuberculosis subunit vaccines expressing PPE44 (Rv2770c).
Romano M; Rindi L; Korf H; Bonanni D; Adnet PY; Jurion F; Garzelli C; Huygen K
Vaccine; 2008 Nov; 26(48):6053-63. PubMed ID: 18822333
[TBL] [Abstract][Full Text] [Related]
9. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
[TBL] [Abstract][Full Text] [Related]
10. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
11. New approaches to identification of antigens of Mycobacterium tuberculosis.
Wallis RS
Infect Agents Dis; 1996 Mar; 5(2):119-25. PubMed ID: 8721048
[TBL] [Abstract][Full Text] [Related]
12. Recombinant and synthetic peptides to identify Mycobacterium tuberculosis antigens and epitopes of diagnostic and vaccine relevance.
Mustafa AS
Tuberculosis (Edinb); 2005; 85(5-6):367-76. PubMed ID: 16253561
[TBL] [Abstract][Full Text] [Related]
13. An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis.
Wang QL; Pan Q; Ma Y; Wang K; Sun P; Liu S; Zhang XL
Vaccine; 2009 Nov; 27(48):6712-22. PubMed ID: 19733584
[TBL] [Abstract][Full Text] [Related]
14. H2 complex controls CD4/CD8 ratio, recurrent responsiveness to repeated stimulations, and resistance to activation-induced apoptosis during T cell response to mycobacterial antigens.
Pichugin AV; Petrovskaya SN; Apt AS
J Leukoc Biol; 2006 Apr; 79(4):739-46. PubMed ID: 16415170
[TBL] [Abstract][Full Text] [Related]
15. Intratracheal administration of third-generation lentivirus vector encoding MPT51 from Mycobacterium tuberculosis induces specific CD8+ T-cell responses in the lung.
Hashimoto D; Nagata T; Uchijima M; Seto S; Suda T; Chida K; Miyoshi H; Nakamura H; Koide Y
Vaccine; 2008 Sep; 26(40):5095-100. PubMed ID: 18514976
[TBL] [Abstract][Full Text] [Related]
16. Human dendritic cells presenting adenovirally expressed antigen elicit Mycobacterium tuberculosis--specific CD8+ T cells.
Lewinsohn DA; Lines RA; Lewinsohn DM
Am J Respir Crit Care Med; 2002 Sep; 166(6):843-8. PubMed ID: 12231495
[TBL] [Abstract][Full Text] [Related]
17. Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection.
Wozniak TM; Ryan AA; Triccas JA; Britton WJ
Infect Immun; 2006 Jan; 74(1):557-65. PubMed ID: 16369012
[TBL] [Abstract][Full Text] [Related]
18. An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis.
Majlessi L; Simsova M; Jarvis Z; Brodin P; Rojas MJ; Bauche C; Nouzé C; Ladant D; Cole ST; Sebo P; Leclerc C
Infect Immun; 2006 Apr; 74(4):2128-37. PubMed ID: 16552042
[TBL] [Abstract][Full Text] [Related]
19. Re-formulation of selected DNA vaccine candidates and their evaluation as protein vaccines using a guinea pig aerosol infection model of tuberculosis.
Vipond J; Clark SO; Hatch GJ; Vipond R; Marie Agger E; Tree JA; Williams A; Marsh PD
Tuberculosis (Edinb); 2006; 86(3-4):218-24. PubMed ID: 16520093
[TBL] [Abstract][Full Text] [Related]
20. Effector functions of heparin-binding hemagglutinin-specific CD8+ T lymphocytes in latent human tuberculosis.
Temmerman ST; Place S; Debrie AS; Locht C; Mascart F
J Infect Dis; 2005 Jul; 192(2):226-32. PubMed ID: 15962217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
